PhRMA Wants Clearer Definition Of Safety “Signal”; FDA Proposes Newsletter

FDA's upcoming pharmacovigilance guidance should include a clearer definition of what constitutes a drug risk "signal," the Pharmaceutical Research & Manufacturers of America maintains

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet